Dr William F Lavelle, MD | |
6620 Fly Road, Suite 200, East Syracuse, NY 13057 | |
(315) 464-4472 | |
(315) 464-5222 |
Full Name | Dr William F Lavelle |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 22 Years |
Location | 6620 Fly Road, East Syracuse, New York |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134247646 | NPI | - | NPPES |
03018619 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207XS0117X | Orthopaedic Surgery - Orthopaedic Surgery Of The Spine | 2496561 (New York) | Secondary |
207X00000X | Orthopaedic Surgery | 249656 (New York) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Hospital S U N Y Health Science Center | Syracuse, NY | Hospital |
Crouse Hospital | Syracuse, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Upstate Orthopedics, Llp | 1456344514 | 32 |
News Archive
Sagient Research Systems, a leading publisher of independent research for the financial services, institutional investment and corporate intelligence communities, recently published an updated report analyzing approval rates at the U.S Food and Drug Administration. According to its research service, BioMedTracker, the rate of drugs that were approved by the FDA in 2008 and 2009 has remained close to the historical low seen in 2007.
GE Money, the consumer lending unit of General Electric Company, and Nautilus, Inc., a global fitness equipment leader, today announced a multi-year agreement to provide consumer financing via Nautilus' direct sales channel.
Malignant melanoma (MM), the most dangerous type of skin cancer, is caused mainly by intense episodes of UV exposure and originates in the pigment-producing melanocytes in the basal layer of the epidermis. Early detection and complete excision of the primary lesions is crucial for reducing melanoma-related deaths but current diagnostic practice is highly subjective. This leads to unnecessary surgical procedures, which are highly-invasive and expensive.
Researchers at Boston Medical Center have found that only a fraction of patients at risk of having their utilities shut off were identified through social determinants of health screening.
› Verified 4 days ago
Entity Name | Auburn Community Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093712911 PECOS PAC ID: 2365346525 Enrollment ID: O20031120000617 |
News Archive
Sagient Research Systems, a leading publisher of independent research for the financial services, institutional investment and corporate intelligence communities, recently published an updated report analyzing approval rates at the U.S Food and Drug Administration. According to its research service, BioMedTracker, the rate of drugs that were approved by the FDA in 2008 and 2009 has remained close to the historical low seen in 2007.
GE Money, the consumer lending unit of General Electric Company, and Nautilus, Inc., a global fitness equipment leader, today announced a multi-year agreement to provide consumer financing via Nautilus' direct sales channel.
Malignant melanoma (MM), the most dangerous type of skin cancer, is caused mainly by intense episodes of UV exposure and originates in the pigment-producing melanocytes in the basal layer of the epidermis. Early detection and complete excision of the primary lesions is crucial for reducing melanoma-related deaths but current diagnostic practice is highly subjective. This leads to unnecessary surgical procedures, which are highly-invasive and expensive.
Researchers at Boston Medical Center have found that only a fraction of patients at risk of having their utilities shut off were identified through social determinants of health screening.
› Verified 4 days ago
Entity Name | Upstate Orthopedics, Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740228311 PECOS PAC ID: 1456344514 Enrollment ID: O20040405001452 |
News Archive
Sagient Research Systems, a leading publisher of independent research for the financial services, institutional investment and corporate intelligence communities, recently published an updated report analyzing approval rates at the U.S Food and Drug Administration. According to its research service, BioMedTracker, the rate of drugs that were approved by the FDA in 2008 and 2009 has remained close to the historical low seen in 2007.
GE Money, the consumer lending unit of General Electric Company, and Nautilus, Inc., a global fitness equipment leader, today announced a multi-year agreement to provide consumer financing via Nautilus' direct sales channel.
Malignant melanoma (MM), the most dangerous type of skin cancer, is caused mainly by intense episodes of UV exposure and originates in the pigment-producing melanocytes in the basal layer of the epidermis. Early detection and complete excision of the primary lesions is crucial for reducing melanoma-related deaths but current diagnostic practice is highly subjective. This leads to unnecessary surgical procedures, which are highly-invasive and expensive.
Researchers at Boston Medical Center have found that only a fraction of patients at risk of having their utilities shut off were identified through social determinants of health screening.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr William F Lavelle, MD 6620 Fly Road, Suite 200, East Syracuse, NY 13057 Ph: (315) 464-4472 | Dr William F Lavelle, MD 6620 Fly Road, Suite 200, East Syracuse, NY 13057 Ph: (315) 464-4472 |
News Archive
Sagient Research Systems, a leading publisher of independent research for the financial services, institutional investment and corporate intelligence communities, recently published an updated report analyzing approval rates at the U.S Food and Drug Administration. According to its research service, BioMedTracker, the rate of drugs that were approved by the FDA in 2008 and 2009 has remained close to the historical low seen in 2007.
GE Money, the consumer lending unit of General Electric Company, and Nautilus, Inc., a global fitness equipment leader, today announced a multi-year agreement to provide consumer financing via Nautilus' direct sales channel.
Malignant melanoma (MM), the most dangerous type of skin cancer, is caused mainly by intense episodes of UV exposure and originates in the pigment-producing melanocytes in the basal layer of the epidermis. Early detection and complete excision of the primary lesions is crucial for reducing melanoma-related deaths but current diagnostic practice is highly subjective. This leads to unnecessary surgical procedures, which are highly-invasive and expensive.
Researchers at Boston Medical Center have found that only a fraction of patients at risk of having their utilities shut off were identified through social determinants of health screening.
› Verified 4 days ago
Dr. Maria Iannolo, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6620 Fly Rd, East Syracuse, NY 13057 Phone: 315-464-4472 Fax: 315-464-5222 | |
Scott M Vanvalkenburg, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6620 Fly Rd, Ste 200, East Syracuse, NY 13057 Phone: 315-464-4472 Fax: 315-464-5229 | |
Dr. Brian J Harley, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6620 Fly Road, Ste 200, East Syracuse, NY 13027 Phone: 315-464-4472 Fax: 315-464-5222 | |
David Cinats, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6620 Fly Rd Ste 100, East Syracuse, NY 13057 Phone: 315-464-4472 | |
Dr. Kathryn E Palomino, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6620 Fly Road, Ste 200, East Syracuse, NY 13057 Phone: 315-464-4472 | |
Robert A Sherman, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6620 Fly Rd, Upstate Orthopedics, East Syracuse, NY 13057 Phone: 315-464-4472 Fax: 315-464-5221 |